New Report Just Published: Global Botulinum ToxinBusiness Wire (press release)... Solstice Neurosciences Inks Licensing Agreement with DreamPharma II-38 Botox Enters India Market II-38 Mentor Begins Phase-I Clinical Trial on Botulinum ...and more »
New Report Just Published: Global Botulinum ToxinBusiness Wire (press release)... Solstice Neurosciences Inks Licensing Agreement with DreamPharma II-38 Botox Enters India Market II-38 Mentor Begins Phase-I Clinical Trial on Botulinum ...and more »